ST. PAUL, Minn., Feb. 25 /PRNewswire/ -- BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).
There was a two-part goal to the project: reach patients in need of care for PAD and lay out a high-quality, cost-effective plan for evaluating a range of diseases utilizing a telemedicine approach.
Gwen Tillman, executive director, PAD Coalition at Vascular Disease Foundation was in attendance to help reinforce the need for rapid diagnosis and treatment of PAD and observe the process.
Significantly under-diagnosed but common, PAD (Peripheral Arterial Disease), sometimes known as peripheral vascular disease or PVD, may be life-threatening if undiagnosed and impacts approximately 5.25% of Americans.. People with PAD have a six to seven times greater risk of suffering coronary artery disease, heart attack and strokes than the risk for people who don’t have PAD, according to the National Heart Lung and Blood Institute. Arteries can slowly become narrowed or blocked as a consequence of age, smoking, high blood cholesterol or diabetes, and less blood reaching the muscles in the legs can make them hurt and increase the risk of clots. PAD can usually be effectively treated by a healthier lifestyle, daily exercise and medications to decrease leg pains and improve one’s chance of avoiding heart attack or stroke.
About Howard University Hospital
About BioMedix
CONTACT: Meg Heim, +1-651-276-9106, Fax: +1-651-846-6887,
MHeim@BioMedix.com
Web site: http://www.BioMedix.com/
